4 Stories

$249 Saliva Test Could Reveal Cancer Risk

Color Genomics aims to 'democratize access to genetic testing'

(Newser) - A Silicon Valley start-up is setting out to make genetic testing for breast and ovarian cancer mutations not only easier, but more affordable for women. Color Genomics says it could "democratize access to genetic testing" for breast cancer risk genes BRCA1 and BRCA2 with a saliva test costing just... More »

Suit Challenges Patenting of Cancer Genes

(Newser) - A group of breast cancer and ovarian cancer patients has filed suit against the Patent Office for allowing a company to patent two human genes, the Courthouse News Service reports. The plaintiffs, who also include medical organizations and the ACLU, allege that Myriad Genetics' patents on the BRCA1 and BRCA2... More »

Family History of Breast Cancer Trumps Genes

Incidence among relatives is red flag, even without mutations

(Newser) - Women with family history of breast cancer are at elevated risk even if they don’t have a proven genetic indicator, HealthDay reports. Specific mutations in the BRCA gene correlate with an 80% lifetime risk of developing breast cancer; women in a new study who had a family history of... More »

Gene Doesn't Alter Cancer Survival Rates

Breast cancer triggered by BRCA1 and BRCA2 no more lethal than other forms

(Newser) - Women who carry one of the two known breast-cancer-causing genes—BRCA1 and BRCA2—are more likely to  be diagnosed with the disease before 50, but they're not more likely to die from it than other breast-cancer patients, a new study concludes. Tracking the 10-year survival rates of women in 22... More »

4 Stories